IDH1/2, which encodes the enzyme isocitrate dehydrogenase, was recently shown to be mutated in about 16% of all AMLs and have significant prognostic impact in CN-AML with mutated NPM1 without FLT3-ITD [4]. Here, FLT3 is linked to acute myeloid leukemia.